Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells

Int J Biochem Cell Biol. 2006;38(12):2173-82. doi: 10.1016/j.biocel.2006.06.014. Epub 2006 Jul 16.

Abstract

Omega-3 polyunsaturated fatty acids have been suggested to play an important role in cancer prevention/progression, on the one hand, and in modulation of membrane ion channels on the other. We investigated whether docosahexaenoic acid would influence the in vitro migration of MDA-MB-231 human breast cancer cells. An important follow-up question was whether any effect would involve voltage-gated Na(+) channels, shown previously to occur in human breast cancer in vitro and in vivo and to correlate with metastatic potential. Short-term (acute) and long-term (24-72 h) application of docosahexaenoic acid suppressed the activity of the channel activity in a dose-dependent manner. At the working concentrations of docosahexaenoic acid used (0.05-0.5 microM), there was no effect on proliferation. Long-term treatment with docosahexaenoic acid down-regulated mRNA and protein (total and plasma membrane) levels of neonatal Nav1.5 voltage-gated Na(+) channel, known to be predominant in these cells. Docosahexaenoic acid suppressed migration of the MDA-MB-231 cells to the same extent as tetrodotoxin, a highly specific blocker of voltage-gated Na(+) channels, but the two effects were not additive. It was concluded that the docosahexaenoic acid-induced suppression of cellular migration occurred primarily via down-regulation of voltage-gated Na(+) channel (neonatal Nav1.5) mRNA and functional protein expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology*
  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Docosahexaenoic Acids / pharmacology*
  • Electrophysiology
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Infant, Newborn
  • Ion Channel Gating / drug effects*
  • Muscle Proteins / antagonists & inhibitors*
  • Muscle Proteins / genetics
  • Muscle Proteins / metabolism*
  • NAV1.5 Voltage-Gated Sodium Channel
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Sodium Channels / genetics
  • Sodium Channels / metabolism*
  • Tetrodotoxin / pharmacology

Substances

  • Muscle Proteins
  • NAV1.5 Voltage-Gated Sodium Channel
  • RNA, Messenger
  • SCN5A protein, human
  • Sodium Channels
  • Docosahexaenoic Acids
  • Tetrodotoxin